KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Accured Expenses (2016 - 2025)

LifeMD filings provide 14 years of Change in Accured Expenses readings, the most recent being -$5.1 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 260.43% to -$5.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.8 million, a 153.77% decrease, with the full-year FY2025 number at -$5.8 million, down 153.77% from a year prior.
  • Change in Accured Expenses hit -$5.1 million in Q4 2025 for LifeMD, down from $4.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $6.2 million in Q3 2023 to a low of -$5.1 million in Q4 2025.
  • Median Change in Accured Expenses over the past 5 years was $771146.0 (2021), compared with a mean of $933122.6.
  • Biggest five-year swings in Change in Accured Expenses: surged 4200.86% in 2023 and later plummeted 1606.02% in 2025.
  • LifeMD's Change in Accured Expenses stood at $771146.0 in 2021, then surged by 83.49% to $1.4 million in 2022, then plummeted by 165.89% to -$932374.0 in 2023, then soared by 437.66% to $3.1 million in 2024, then crashed by 260.43% to -$5.1 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$5.1 million (Q4 2025), $4.5 million (Q3 2025), and -$3.0 million (Q2 2025) per Business Quant data.